1. Home
  2. XRTX vs HYFM Comparison

XRTX vs HYFM Comparison

Compare XRTX & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$2.00

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

HOLD

Current Price

$1.07

Market Cap

4.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRTX
HYFM
Founded
2011
1977
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.4M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
XRTX
HYFM
Price
$2.00
$1.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7M
28.3K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$134,252,000.00
Revenue This Year
N/A
$57.44
Revenue Next Year
N/A
$5.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$0.79
52 Week High
$3.60
$4.78

Technical Indicators

Market Signals
Indicator
XRTX
HYFM
Relative Strength Index (RSI) 41.83 51.88
Support Level $0.41 $0.82
Resistance Level $3.03 $1.09
Average True Range (ATR) 0.24 0.09
MACD -0.15 -0.00
Stochastic Oscillator 4.49 33.38

Price Performance

Historical Comparison
XRTX
HYFM

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

Share on Social Networks: